风险因素对干预和非干预冠状动脉病变的影响
Xincheng Sheng1, Gan Yang1, Qing Zhang1
1Department of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiaotong University 160 Pu Jian Road, Shanghai 200127, China.
American journal of cardiovascular disease
|September 23, 2024
概括
血糖和慢性病对静脉静脉缩 (ISR) 和加重的非干预性冠状动脉病变 (ANL) 都有影响. 升高的脂质,特别是非HDL-C和ApoB,是冠状动脉疾病患者的ANL的风险因素.
科学领域:
- 心脏病学 心脏病学
- 血管生物学 血管生物学
- 临床研究 临床研究
背景情况:
- 静脉静脉复缩 (ISR) 和加重的非干预性冠状动脉病变 (ANL) 是冠状动脉疾病 (CAD) 进展的关键问题.
- 常见的危险因素包括高脂血症,高血压,糖尿病,慢性病和吸烟.
- 对ISR和ANL进展的比较风险因素分析是有限的.
研究的目的:
- 分析和比较相同风险因素对ISR和ANL的不同影响.
- 确定有助于疾病进展的特定风险因素,在患有CAD后皮肤冠状动脉干预 (PCI) 的患者中.
主要方法:
- 该研究包括510名患有多重冠状动脉病变的患者,接受了重复冠状动脉血管学 (CAG).
- 患者之前曾经进行过PCI,并且已有未进行干预的冠状动脉病变.
主要成果:
- 血红蛋白A1c (HbA1c) 和尿蛋白 (UA) 是ISR的独立风险因素.
- HbA1c,血清肌素 (Scr) 和阿波利波蛋白B (ApoB) 是ANL的独立风险因素.
- 非高密度脂蛋白胆固醇 (非高密度脂蛋白胆固醇-C) 和ApoB水平在仅用ANL的组中明显高于仅用ISR的组.
结论:
- 血糖 (HbA1c) 和慢性病 (Scr) 是ISR和ANL的独立风险因素.
- 升高的脂质水平,特别是非HDL-C和ApoB,与ANL进展有显著的关联.
- 监测非HDL-C和ApoB对于评估PCI后未进行干预的病变患者的风险至关重要.
相关概念视频
01:17Ischemic Heart Disease: Overview
1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
01:27Psychoneuroimmunology: Cardiovascular Disease
26
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
26
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
01:20Exercise and Cardiovascular Response
745
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
745
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
462
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
462